AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Aug 28 2023
Fact Check
No Support for Viral Claim That COVID-19 ‘Lockdowns’ Are Returning This Fall
In recent weeks, COVID-19 cases, as estimated from wastewater data, and COVID-19 hospitalizations have been on the rise in the U.S. This comes as the omicron variant EG.5, recently designated as a “variant of interest” by the World Health Organization, became the newly dominant variant in the country.
This has led some public health experts to suggest that some people — especially those
FactCheck.orgNov 01 2023
News
Nebraska lawmakers, medical professionals weigh statewide COVID-19 response
LINCOLN, Neb. (KOLN) - Building a plane while flying it—that’s how one expert testifier described the work of responding to the COVID-19 pandemic at a Nebraska legislative hearing on Wednesday. It was an experience that caught the world and Nebraska medical professionals completely off guard, so now, state leaders are trying to bring together the lessons learned and weigh the state’s response
KOLNFeb 06 2024
News
Not wearing mask during COVID-19 outbreak isn’t protected by free speech, court rules
A federal appeals court in New Jersey ruled Monday that residents’ refusal to wear face masks at a school board meeting during the COVID-19 pandemic is not protected as a free speech right. The 3rd Circuit Court of Appeals issued a ruling in two similar cases that stemmed from lawsuits against officials in Freehold and Cranford, New Jersey. The plaintiffs refused to wear masks during public
The HillDec 29 2020
News
Here’s the latest on COVID-19 vaccines
In the first data available since authorized immunizations began in the U.S. in December, the CDC reports 353 adverse events. Roughly 1.9 million doses have been served nationwide. Novavax has begun a phase three study of its COVID-19 vaccine in the U.S. and Mexico. The study will evaluate the vaccine’s safety and efficacy in up to 30,000 adults. The European Union has launched its mass
National GeographicDec 29 2020
Fact Check
A Guide to Moderna’s COVID-19 Vaccine
Moderna’s mRNA vaccine is the second COVID-19 vaccine authorized for use in the U.S. Here, we give a rundown of basic facts about the vaccine and an overview of how it works.
Quick Summary Vaccine name: mRNA-1273
Design type: mRNA
Dose number: 2 doses, 28 days apart
Efficacy: 94.1% efficacy in preventing symptomatic COVID-19 in adults two weeks or more after receipt
FactCheck.orgMay 05 2023
News
WHO Declares Covid-19 Pandemic Emergency Over
The World Health Organization declared an end to the Covid-19 emergency, signaling that one of the most deadly and economically devastating pandemics in modern history is receding as the disease that caused it becomes a routine illness.
Covid-19 is here to stay, but the pandemic has been in a downward trend for more than a year because people around the world have built up immunity to
Wall Street Journal (News)Dec 23 2020
Fact Check
A Guide to Moderna’s COVID-19 Vaccine
Moderna’s mRNA vaccine is the second COVID-19 vaccine authorized for use in the U.S. Here, we give a rundown of basic facts about the vaccine and an overview of how it works.
Quick Summary - Vaccine name: mRNA-1273
Design type: mRNA; Dose number: 2 doses, 28 days apart
Efficacy: 94.1% efficacy in preventing symptomatic COVID-19 in adults two weeks or more after receipt of
FactCheck.orgSep 26 2022
News
Q&A on Omicron-Updated COVID-19 Boosters
Earlier this month, the U.S. began administering the first COVID-19 booster vaccines that have been updated to better match the latest circulating coronavirus strains.
Many scientists expect the revised boosters will be more effective than their predecessors, but whether that’s the case and to what degree remains unknown.
The new vaccines, from mRNA vaccine makers Pfizer/BioNTech
FactCheck.orgDec 14 2020
Analysis
The Covid-19 vaccine’s 2 big challenges
The US has authorized a coronavirus vaccine. That doesn’t guarantee a quick end to the pandemic.
America has, finally, authorized a Covid-19 vaccine for the general public. Priority groups — health care workers and people in nursing homes — are now starting to get a vaccine. And if things go right, most of the country could be vaccinated by the end of next summer.
But that’s the
VoxDec 09 2020
Analysis
COVID-19 and the U.S. Fiscal Imbalance
Before COVID-19, the U.S. debt burden was large and on an unsustainable path under reasonable assumptions about economic fundamentals. Standard policy responses, such as higher taxes or lower discretionary spending, could not substantially slow the growth of the U.S. debt burden; only reduced growth in entitlement spending, especially on Medicare, had the potential to avoid eventual fiscal
Cato Institute